Mov Disord Vol 35, Suppl 1 Archives - Page 125 of 149 - MDS Abstracts

MDS Virtual Congress 2020
Engaging the Denver Hispanic Community in Parkinson’s Disease Research
M. Fullard, G. Matthewson, S. Holden, R. Mullen, J. Parra Gonzalez, J. Feuerstein, H. Hemley, B. Siddiqi, L. Seeberger (Aurora, CO, USA)
Objective: To raise awareness about Parkinson’s disease (PD) and PD research in the Hispanic/Latino (H/L) community and increase representation of this group in PD research.…
MDS Virtual Congress 2020
Canine Aromatic Detection of Parkinson’s Disease: Can Dogs Identify Prodromal Parkinsonism?
L. Mischley, J. Farahnik (Lake Forest Park, WA, USA)
Objective: The goal of this study was to determine whether canine aromatic detection could be used to detect patients with clinically diagnosed PD. Background: The…
MDS Virtual Congress 2020
Biomarkers in Functional Movement Disorders: A Systematic Review
B. Thomsen, T. Teodoro, M. Edwards (Copenhagen, Denmark)
Objective: This is a systematic review performed to investigate current and potential biomarkers in functional movement disorders (FMD). Background: FMD are proposed to reflect a…
MDS Virtual Congress 2020
Type 2 diabetes mellitus may worsen severity of motor symptoms in people with Parkinson’s disease
A. Ben-Joseph, T. Haque, D. Gallagher, C. Budu, R. Chaudhuri, C. Simonet, A. Noyce (London, United Kingdom)
Objective: We aimed to determine whether co-morbid type 2 diabetes mellitus (T2DM) would impact the motor or non-motor symptom severity in people with Parkinson’s (PwP).…
MDS Virtual Congress 2020
The role of dementia in Parkinson’s disease
A. Aralbayeva, A. Kondybaeva, S. Kamenova, K. Kuzhibaeva (Almaty, Kazakhstan)
Objective: To identify cognitive and visual-spatial disorders in patients with Parkinson's disease. Background: In the clinical picture of Parkinson's disease, non-motor symptoms acquire great importance,…
MDS Virtual Congress 2020
The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset
E. Fiorenzato, A. Antonini, W. Weis, P. Bisiacchi, C. Semenza, A. Vallesi, R. Biundo (Venice, Italy)
Objective: To characterize the impact of asymmetric dopaminergic degeneration, measured with I123-ioflupane SPECT (DATSCAN), on cortical integrity and cognitive deficits, in de-novo right-handed PD patients.…
MDS Virtual Congress 2020
Association of gait domains with cognitive and neuropsychiatric domains in patients with Parkinson’s disease: A Brazilian exploratory study
E. Lirani-Silva, R. Vitorio, D. Orcioli-Silva, P. Nobrega-Souza, N. Conceição, V. Beretta, L. Gobbi (Portland, OR, USA)
Objective: (i) To examine the association of gait domains (single and dual task (DT) walk) with cognitive and neuropsychiatric domains in patients with Parkinson’s disease…
MDS Virtual Congress 2020
Clinical outcomes after DBS surgery in cognitively impaired patients with PD
M. Patel, E. Staikova, D. Loring, M. DeLong, S. Triche, C. Esper, T. Wichmann, L. Scorr, L. Higginbotham, P. Aia, S. Factor, C. Buetefisch, S. Miocinovic (Atlanta, GA, USA)
Objective: To describe clinical outcomes after DBS in patients with PD and moderate cognitive impairment (CI). Background: DBS is generally contraindicated in PD patients with…
MDS Virtual Congress 2020
Investigating Factors Contributing to Parkinson’s disease-related Cognitive Decline
P. Tipton, N. Bulbul, J. Crook, O. Ross, Z. Wszolek, N. Ertekin-taner (Jacksonville, FL, USA)
Objective: The objective of this study was to identify predictive factors of cognitive decline in patients with Parkinson’s disease (PD). Background: Among those with PD,…
MDS Virtual Congress 2020
Blood alpha-synuclein profile and lysosomal alterations distinguish GBA1-related Parkinson’s disease from sporadic Parkinson’s disease
M.A Avenali, S.C Cerri, G.O Ongari, C.P Pacchetti, C.T Tassorelli, E.V Valente, F.B Blandini (Pavia, Italy)
Objective: This study aims to characterize blood profile of alpha-synuclein and the main lysosomal proteinsas well as clinical features of PD subjects carrying GBA1 mutations…